N1,N1-Diisopropylethane-1,2-diamine, 95.0%, 25g

2-Methoxyethane-1-sulfonyl fluoride, 97%, 2.5g

Plan PLPHi S100x/1,25 objectif corrigé à l'infini pour IOS à contraste de phase

4-Chloro-2-(methylthio)pyrimidine-5-carbaldehyde, 95.0%, 5g

NIK INHIBITOR, 98.0%, 100mg

Methyl 1-Aminocyclopentanecarboxylate Hydrochloride>98.0%(T)1g

N-Hydroxysulfosuccinimide Sodium Salt>98.0%(HPLC)(T)1g

1-(3,4-Dichlorophenyl)cyclopropane-1-carboxylic acid, 97%, 1g

1-Acetylindolin-3-one, 95.0%, 5g

Oleanolic Acid>98.0%(T)25g

2-Methoxy-5-(trifluoromethoxy)benzaldehyde, 97.0%, 100g

3-(5-HYDROXY-1-OXOISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE, 95%, 500mg

2,3,5-Trimethylphenol, 95.0%, 500g